Open Access
Subscription Access
Understanding Myocardial Diseases in Humans
Abstract
Myocardial diseases impact the heart muscle. These conditions can have various causes and can lead to health implications in a significant manner. Myocardial infarction happens when blood flow to a part if the heart is obstructed, resulting on the death of the heart muscles because if lack of oxygen. Symptoms include chest pain or discomfort, shortness of breath, nausea and sweating. Types of cardiomyopathy include dilated cardiomyopathy, hypertrophic cardiomyopathy ND restrictive cardiomyopathy. Chest pain, fever, exhaustion, and palpitations are signs of myocardititis. In arthythmogenic right ventricular cardiomyopathy (ARVC), a rare hereditary disorder, the right ventricle's heart muscle gradually gives way to fatty and fibrous tissue. Symptoms of ARVC are palpitations, fainting and Cardiac arrest. Treatment is based on life style changes. Medications, Cardiac rehabilitation and in some cases procedures namely angioplasty or heart surgery. Finally it is concluded that myocardial disease encompass range of conditions influencing the heart muscle, with causes ranging from genetic factors to life style choices.
References
Thygesen K, Alpert JS, White HD, Joint ESC/ACCF/AHA/WHF Task Force for the Redefinition of Myocardial Infarction. Jaffe AS, Apple FS, Galvani M, Katus HA, Newby LK, Ravkilde J, Chaitman B, Clemmensen PM, Dellborg M, Hod H, Porela P, Underwood R, Bax JJ, Beller GA, Bonow R, Van der Wall EE, Bassand JP, Wijns W, Ferguson TB, Steg PG, Uretsky BF, Williams DO, Armstrong PW, Antman EM, Fox KA, Hamm CW, Ohman EM, Simoons ML, Poole-Wilson PA, Gurfinkel EP, Lopez-Sendon JL, Pais P, Mendis S, Zhu JR, Wallentin LC, Fernández-Avilés F, Fox KM, Parkhomenko AN, Priori SG, Tendera M, Voipio-Pulkki LM, Vahanian A, Camm AJ, De Caterina R, Dean V, Dickstein K, Filippatos G, Funck-Brentano C, Hellemans I, Kristensen SD, McGregor K, Sechtem U, Silber S, Tendera M, Widimsky P, Zamorano JL, Morais J, Brener S, Harrington R, Morrow D, Lim M, Martinez-Rios MA, Steinhubl S, Levine GN, Gibler WB, Goff D, Tubaro M, Dudek D, Al-Attar N. (2007). Universal definition of myocardial infarction. Circulation, 116(22), 2634-53. Reimer, K. A., Jennings, R. B., & Tatum, A. H. (1983). Pathobiology of acute myocardial ischemia: metabolic, functional and ultrastructural studies. The American journal of cardiology, 52(2), 72-81.
Apple, F. S., Sandoval, Y., Jaffe, A. S., & Ordonez-Llanos, J. (2017). Cardiac troponin assays: guide to understanding analytical characteristics and their impact on clinical care. Clinical chemistry, 63(1), 73-81.
Goodman, S. G., Steg, P. G., Eagle, K. A., Fox, K. A., López-Sendón, J., Montalescot, G., ... & GRACE Investigators. (2006). The diagnostic and prognostic impact of the redefinition of acute myocardial infarction: lessons from the Global Registry of Acute Coronary Events (GRACE). American heart journal, 151(3), 654-660.
Yusuf, S., Hawken, S., Ôunpuu, S., Dans, T., Avezum, A., Lanas, F., ... & Lisheng, L. (2004). Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. The lancet, 364(9438), 937-952.
Anand, S. S., Islam, S., Rosengren, A., Franzosi, M. G., Steyn, K., Yusufali, A. H., ... & Yusuf, S. (2008). Risk factors for myocardial infarction in women and men: insights from the INTERHEART study. European heart journal, 29(7), 932-940.
Stampfer, M. J., Malinow, M. R., Willett, W. C., Newcomer, L. M., Upson, B., Ullmann, D., ... & Hennekens, C. H. (1992). A prospective study of plasma homocyst (e) ine and risk of myocardial infarction in US physicians. Jama, 268(7), 877-881.
Nielsen, M., Andersson, C., Gerds, T. A., Andersen, P. K., Jensen, T. B., Køber, L., ... & Torp-Pedersen, C. (2013). Familial clustering of myocardial infarction in first-degree relatives: a nationwide study. European heart journal, 34(16), 1198-1203.
BHF Family Heart Study Research Group. (2005). A genomewide linkage study of 1,933 families affected by premature coronary artery disease: The British Heart Foundation (BHF) Family Heart Study. The American Journal of Human Genetics, 77(6), 1011-1020.
Wang, Q., Rao, S., Shen, G. Q., Li, L., Moliterno, D. J., Newby, L. K., ... & Topol, E. J. (2004). Premature myocardial infarction novel susceptibility locus on chromosome 1P34-36 identified by genomewide linkage analysis. The American Journal of Human Genetics, 74(2), 262-271.
Thom T, Haase N, Rosamond W, Howard VJ, Rumsfeld J, Manolio T, Zheng ZJ, Flegal K, O'Donnell C, Kittner S, Lloyd-Jones D, Goff DC, Hong Y, Adams R, Friday G, Furie K, Gorelick P, Kissela B, Marler J, Meigs J, Roger V, Sidney S, Sorlie P, Steinberger J, Wasserthiel-Smoller S, Wilson M, Wolf P., American Heart Association Statistics Committee and Stroke Statistics Subcommittee. (2006). Heart disease and stroke statistics--2006 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation, 113(6), e85-151.
Benjamin, E. J., Virani, S. S., Callaway, C. W., Chamberlain, A. M., Chang, A. R., Cheng, S., ... & Muntner, P. (2018). Heart disease and stroke statistics—2018 update: a report from the American Heart Association. Circulation, 137(12), e67-e492.
Frangogiannis, N.G. (2015). Pathophysiology of Myocardial Infarction. Compr Physiol, 5(4), 1841-75.
Thygesen, K., Alpert, J. S., Jaffe, A. S., Chaitman, B. R., Bax, J. J., Morrow, D. A., & White, H. D. (2019). Fourth universal definition of myocardial infarction (2018). European heart journal, 40(3), 237-269.
Mendis, S., Thygesen, K., Kuulasmaa, K., Giampaoli, S., Mähönen, M., Ngu Blackett, K., ... & Writing group on behalf of the participating experts of the WHO consultation for revision of WHO definition of myocardial infarction. (2011). World Health Organization definition of myocardial infarction: 2008–09 revision. International journal of epidemiology, 40(1), 139-146.
Malik, M. A., Khan, S. A., & Safdar, S. (2013). Chest Pain as a presenting complaint in patients with acute myocardial infarction (AMI). Pakistan journal of medical sciences, 29(2), 565.
Damman, P., van’t Hof, A. W., Ten Berg, J. M., Jukema, J. W., Appelman, Y., Liem, A. H., & de Winter, R. J. (2017). 2015 ESC guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: comments from the Dutch ACS working group. Netherlands Heart Journal, 25, 181-185.
Thygesen K, Alpert JS, Jaffe AS, Simoons ML, Chaitman BR, White HD, Writing Group on the Joint ESC/ACCF/AHA/WHF Task Force for the Universal Definition of Myocardial Infarction. Thygesen K, Alpert JS, White HD, Jaffe AS, Katus HA, Apple FS, Lindahl B, Morrow DA, Chaitman BA, Clemmensen PM, Johanson P, Hod H, Underwood R, Bax JJ, Bonow RO, Pinto F, Gibbons RJ, Fox KA, Atar D, Newby LK, Galvani M, Hamm CW, Uretsky BF, Steg PG, Wijns W, Bassand JP, Menasché P, Ravkilde J, Ohman EM, Antman EM, Wallentin LC, Armstrong PW, Simoons ML, Januzzi JL, Nieminen MS, Gheorghiade M, Filippatos G, Luepker RV, Fortmann SP, Rosamond WD, Levy D, Wood D, Smith SC, Hu D, Lopez-Sendon JL, Robertson RM, Weaver D, Tendera M, Bove AA, Parkhomenko AN, Vasilieva EJ, Mendis S., ESC Committee for Practice Guidelines (CPG). (2012). Third universal definition of myocardial infarction. Eur Heart J., 33(20), 2551-67.
Ibanez B, James S, Agewall S, Antunes MJ, Bucciarelli-Ducci C, Bueno H, Caforio ALP, Crea F, Goudevenos JA, Halvorsen S, Hindricks G, Kastrati A, Lenzen MJ, Prescott E, Roffi M, Valgimigli M, Varenhorst C, Vranckx P, Widimský P., ESC Scientific Document Group. (2018). 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: The Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC). Eur Heart J., 39(2), 119-177. [PubMed]
Weil BR, Suzuki G, Young RF, Iyer V, Canty JM. (2018). Troponin Release and Reversible Left Ventricular Dysfunction After Transient Pressure Overload. J Am Coll Cardiol., 71(25), 2906-2916. [PMC free article] [PubMed]
Thygesen K, Mair J, Giannitsis E, Mueller C, Lindahl B, Blankenberg S, Huber K, Plebani M, Biasucci LM, Tubaro M, Collinson P, Venge P, Hasin Y, Galvani M, Koenig W, Hamm C, Alpert JS, Katus H, Jaffe AS., Study Group on Biomarkers in Cardiology of ESC Working Group on Acute Cardiac Care. (2012). How to use high-sensitivity cardiac troponins in acute cardiac care. Eur Heart J., 33(18), 2252-7. [PubMed]
Meine TJ, Roe MT, Chen AY, Patel MR, Washam JB, Ohman EM, Peacock WF, Pollack CV, Gibler WB, Peterson ED., CRUSADE Investigators. (2005). Association of intravenous morphine use and outcomes in acute coronary syndromes: results from the CRUSADE Quality Improvement Initiative. Am Heart J., 149(6), 1043-9. [PubMed]
Bonin M, Mewton N, Roubille F, Morel O, Cayla G, Angoulvant D, Elbaz M, Claeys MJ, Garcia-Dorado D, Giraud C, Rioufol G, Jossan C, Ovize M, Guerin P., CIRCUS Study Investigators. (2018). Effect and Safety of Morphine Use in Acute Anterior ST-Segment Elevation Myocardial Infarction. J Am Heart Assoc., 7(4) [PMC free article] [PubMed]
Refbacks
- There are currently no refbacks.